Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Rani Therapeutics (RANI)

Annual Return

Over the past 3 years, RANI has had an average annual return of -45.74%, underperforming the benchmark SPY, which returned +19.63% annual.

Since Jul 30, 2021, RANI has had an average annual return of -42.65%, underperforming the benchmark SPY, which returned +12.86% annual.

202620252024202320222021
-48.82%-1.45%-58.75%-43.74%-63.91%+48.64%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-10.35%+13.18%-46.35%+20.81%+7.06%-20.02%-9.12%-48.82%
2025+1.53%+10.05%-17.69%-11.88%-49.65%-8.07%+4.28%-4.72%-2.16%+340.53%-27.25%-15.67%-1.45%
2024+4.21%+8.11%-16.85%+105.16%-13.79%-30.90%-25.53%+13.06%-32.49%+6.01%-11.82%-32.19%-58.75%
2023-6.95%+14.75%-18.09%-8.91%-13.20%+0.97%+3.90%-11.21%-42.78%-9.86%+1.01%+67.67%-43.74%
2022+26.78%-19.49%-19.11%-9.41%-6.78%-9.39%+8.90%-20.89%+7.64%-36.33%+35.74%-28.74%-63.91%
2021+0%+67.64%-3.36%+29.07%+28.87%-44.84%+48.64%

Drawdown analysis of Rani Therapeutics (RANI)

The maximum drawdown for the RANI was -98.83%, occurring on Jul 16, 2025. This drawdown has not yet recovered.

The current RANI drawdown is -98.03%.

Since Jul 30, 2021 RANI has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 3 times
  • 10% or more: 4 times
DepthStartTo BottomBottomTo RecoverEndTotal
-98.83%Nov 18, 2021915Jul 16, 2025OngoingOngoingOngoing
-25.36%Aug 11, 20213Aug 16, 202119Sep 13, 202122
-24.92%Sep 13, 202117Oct 6, 202115Oct 27, 202132
-17.37%Nov 4, 20212Nov 8, 20217Nov 17, 20219
-9.94%Oct 28, 20211Oct 29, 20212Nov 2, 20213
-2.73%Jul 30, 20212Aug 3, 20211Aug 4, 20213
-0.26%Aug 4, 20212Aug 6, 20211Aug 9, 20213